Tel: +41 21 692 5630. 14 15 Running title: Ligand binding pocket redesign of Ribose-binding protein 16 Keywords: Rosetta, RbsB, ribose, 1,3-cyclohexanediol, reporter bacteria, fluorescence-assisted bead 17 sorting, protein folding 18 19 20 2 21 Bacterial periplasmic-binding proteins have been acclaimed as general biosensing platform, but 22 their range of natural ligands is too limited for optimal development of chemical compound 23 detection. Computational redesign of the ligand-binding pocket of periplasmic-binding proteins 24 may yield variants with new properties, but, despite earlier claims, genuine changes of specificity 25 to non-natural ligands have so far not been achieved. In order to better understand the reasons of 26 such limited success, we revisited here the Escherichia coli RbsB ribose-binding protein, aiming to 27 achieve perceptible transition from ribose to structurally related chemical ligands 1,3-28 cyclohexanediol and cyclohexanol. Combinations of mutations were computationally predicted for 29 nine residues in the RbsB binding pocket, then synthesized and tested in an E. coli reporter chassis. 30 Two million variants were screened in a microcolony-in-bead fluorescence-assisted sorting 31 procedure, which yielded six mutants no longer responsive to ribose but with 1.2-1.5 times 32 induction in presence of 1 mM 1,3-cyclohexanediol, one of which responded to cyclohexanol as 33 well. Isothermal microcalorimetry confirmed 1,3-cyclohexanediol binding, although only two 34 mutant proteins were sufficiently stable upon purification. Circular dichroism spectroscopy 35 indicated discernable structural differences between these two mutant proteins and wild-type 36 RbsB. This and further quantification of periplasmic-space abundance suggested most mutants to 37 be prone to misfolding and/or with defects in translocation compared to wild-type. Our results 38 thus affirm that computational design and library screening can yield RbsB mutants with 39 recognition of non-natural but structurally similar ligands. The inherent arisal of protein instability 40 or misfolding concomitant with designed altered ligand-binding pockets should be overcome by 41 new experimental strategies or by improved future protein design algorithms. 42 43 Periplasmic binding proteins (PBPs) form a versatile superfamily of proteins with a conserved protein 44 structure, named the bilobal structural fold 1,2 . PBPs facilitate nutrient and trace mineral scavenging 45 for bacterial cells, by binding the ligand in the periplasmic space at high affinity and delivering the 46 bound-ligand to a specific membrane-spanning transport channel 2 . Some PBPs are additionally 47 involved in chemotactic sensing and interact in the ligand-bound state with a membrane-located 48 chemoreceptor 3 . The crystal structures of several PBPs have been determined, showing two domains 49 connected by a hinge region, with the binding pocket located between the two domains 3 . Both 50 structure and nuclear-magnetic resonance data indicate that PBPs switch between two semi-stable 51 conformations. Without ligand the protein adopts an open conformation, in which the binding site is 52 exposed. Suitable ligand molecules become buried within the surrounding protein, and stabilize the 53 closed protein form 4,5 . High-quality crystal structures of various PBPs have been determined, and this 54 triggered pioneering ideas more than a decade ago to deploy PBPs as a generalized platform for 55 computational design-based construction of new ligand-binding properties 6 . PBPs form an 56 interesting class of proteins for biosensing. Biosensing can be achieved by measuring the 57 intermolecular motion of the purified protein itself upon interaction with the target ligand 7 . 58 Alternatively, the PBP protein is expressed in a living bacterial cell and triggers a synthetic signaling 59 cascade upon ligand binding. This principle is embedded in so-called bioreporter cells or 60 bactosensors 8 . By maintaining a single unique signaling cascade and reporter output, but varying the 61 PBP-element with different ligand recognition, one could potentially develop a wide class of 62 applicable bioreporters. 63 The concept of computational design of PBP variants with novel ligand-binding properties 64 was proposed over a decade ago by the group of Hellinga and coworkers 9 . On the examples of five 65 different PBPs in Escherichia coli they predicted and constructed mutant variants with binding 66 pockets accommodating the non-natural substrates trinitrotoluene (TNT), lactate or serotonin at 67 reported nM-mM in vitro affinities 9 . Particularly mutants of the ribose binding protein (RbsB) for TNT 68 were further embedded in an E. coli synthetic bioreporter, in which ligand-bound RbsB-mutant 69 contacts the Trz1 hybrid membrane receptor, increasing expression of a reporter gene fused to the 70 ompC promoter 9 . This Trz1 receptor consists of a fusion of the 230 C-terminal amino acids of the E. 71 coli EnvZ osmoregulation histidine kinase to the 265 N-terminal amino acids of the Trg methyl-72
accepting chemotaxis receptor protein 10 . Contact activation of Trz1 by ligand-bound RbsB triggers 73 autophosphorylation of the cytoplasmic EnvZ-domain, leading to subsequent phosphorylation of the 74 cognate response regulator OmpR, which activates the ompC promoter 11 . Independent engineering 75 of the most sensitive published RbsB mutant (named TNT.R3), however, failed to reproduce the 76 reported TNT detection at sub-µM concentrations in the E. coli Trz1-OmpR background and also 77 failed to demonstrate TNT binding by a purifed TNT.R3 mutant using in vitro microcalorimetry 12 . 78 Subsequent analysis of effects of alanine-substitutions in wild-type E. coli RbsB showed that 79 mutations at 12 positions result in misfolded or poorly translocated proteins, one of which was also 80 targeted in the TNT.R3 variant 13 . Purification and biophysical analysis of a further set of published 81 mutant PBPs also failed to reproduce the original measurements, and suggested the cause being 82 their misfolding and unintended oligomerization 14 . The initial studies may thus have underestimated 83 to a large extent the propensity of PBPs to become misfolded as a result of binding pocket 84 mutations. 85
More recently, ligand-specificities have been successfully interchanged between PBPs by 86 using binding-pocket grafting (i.e., exchange of binding pockets between functionally closely related 87 PBPs) 15, 16 , improved prediction of native ligand binding 17 and statistical coupling analysis (i.e., the 88 prediction of mutations based on correlating amino acid residues in sectors of two classes of related 89 proteins) 15 . So far, however, there have been no reports of non-cognate altered ligand-binding 90 properties of PBPs. The goal of the underlying work was thus to revisit the concept of computational 91 prediction of altered ligand-binding in RbsB. Because of the apparent difficulties to predict structure-92 function related side-effects such as protein folding, we hypothesized that predictions of minor 93 changes in ligand-specificity might be more successful than major ones (e.g., from ribose to TNT). We 94 thus chose to target molecules structurally related to ribose, in particular, 1,3-cyclohexanediol 95 (13CHD) and cyclohexanol (CH). The computational protein design was based on exploration of 96 sequence-space and estimations of Free energy of binding using Rosetta 18-20 , to identify a list of 97 mutated protein sequences with potentially sufficiently low energy of binding with the new target 98 ligands. The DNA encoding for a large set of approximately 2 million mutants was then chemically 99 synthesized and cloned into a vector for screening of inducible GFP expression in the E. coli Trz1-100 OmpR, ompCp::gfp signaling reporter background 12 . Mutant libraries were screened on bead-101 encapsulated microcolony-grown cells by flow cytometry and sorted using fluorescence-assisted 102 bead-sorting (FABS) (Fig. 1) . Positively-responding mutant strains were recovered, their RbsB mutant 103 proteins were purified and further characterized for in vitro ligand binding by isothermal 104 microcalorimetry. Periplasmic abundance of the mutant proteins was quantified by peptide mass-105 spectrometry in comparison to wild-type RbsB, and their folding was addressed by circular dichroism 106 spectroscopy. We recovered a small number of mutants with modest inducibility but significant 107 change in ligand-binding specificity compared to wild-type RbsB and ribose, indicating that the 108 computational design correctly targeted the intended new ligand-binding properties. However, 109 despite some of gain of inducibility, our results indicate the mutant proteins to be unstable, and 110 prone to misfolding during synthesis and secretion. 111 112
Results

113
RbsB mutant library design. Exploration of sequence space using Rosetta enzyme design simulations 114 produced a library of targeted RbsB mutants, which were predicted to have improved affinity for the 115 non-cognate ligands 13CHD and/or CH. The used design template was the scaffold of wild-type 116 ribose-binding protein RbsB of E. coli in its closed configuration (PBD ID: 2DRI, Fig. 2A ). First, prior to 117 the design simulations, interactions between RbsB and ribose, 13CHD or CH were studied using 118 docking and molecular dynamics simulations in CHARMM and Merck Molecular Force Fields (MMFF), 119 to gain intuition on the stability of the binding pocket. The average spatial deviation of the RbsB 120 binding pocket with placed ribose during 2 ns (as the root-mean squared deviation) was less than 0.2 121 Å, but for docked 13CHD and CH molecules was around 0.3 Å. The ligands themselves showed 122 varying positions with an average root-mean squared deviation of 0.7 Å for ribose, 1 Å for 13CHD and 123 1.5 Å for CH. Calculated free energies of binding (ΔG binding ) from CHARMM and MMFF were lowest for 124 ribose, as expected, with -38.35 kcal mol -1 , but -19.57 kcal mol -1 for 13CHD and -14.31 kcal mol -1 for 125 CH. These results indicated unstable interactions of 13CHD and CH in the wild-type RbsB binding 126 pocket. We conducted a per-residue free energy decomposition analysis 21 using the simulation 127 trajectories. The poorer ∆G binding of 13CHD and CH seemed largely contributed by the RbsB residues 128 D89, R90 and D215 (for 13CHD), and D89, D191 and D215 (for CH) (Fig. S1 ). 129
Next, we used Rosetta to predict potential beneficial mutations in RbsB for binding of 13CHD 130 and CH. Defined key residues in the RbsB binding pocket (Table 1 , Fig. 2B ) were computationally 131 replaced by alanine. The 13CHD and CH molecules were then docked 1000 times independently into 132 the ''stripped'' binding pocket to obtain the positions with the lowest minimal binding energy, which 133 were used as a starting point for the design mode. Design simulations (100 repetitions each 134 producing 100 designs) then explored the combinatorial mutations on the defined 9 positions, from 135 which pool 200 sequences were ranked according to the lowest predicted binding energy, minimal 136 packing energy, hydrogen bond counts, and ligand-solvent exposure. This yielded a list of one of four 137 possible amino acids at the 9 positions in RbsB (Table 1) . The DNA encoding these RbsB variants in all 138 their combinations plus the original wild-type residue was produced as a mixed library by DNA 139 synthesis, cloned and introduced into an E. coli host enabling GFPmut2 production through the 140 hybrid Trz1-OmpR signaling chain (strain 4172, Table 2 , Fig. S2 ). Independent cloning reactions 141 resulted in three mutant libraries with estimated sizes of 7×10 6 , 24×10 6 and 3.3×10 6 primary 142
transformants. 143
A total of 4×10 8 alginate beads encapsulating individual cells from the mutant libraries and 144 grown to microcolonies was screened by FABS for GFPmut2 fluorescence, in first instance in absence 145 of inducer ( Fig. 1A ). An estimated 0.53 ± 0.28 % of the screened beads displayed fluorescence above 146 1200 units under non-induced conditions, and were considered constitutive-ON mutants. 147
Approximately 60 million beads with fluorescence below 1000 units were sorted and recovered as 148 mixture. Cells were released from the beads, freshly cultured, encapsulated in new alginate beads, 149 regrown to microcolonies and induced with 1 mM 13CHD (Fig. 1B ). In this second phase, beads with a 150 fluorescence level higher than 1000 units were sorted and plated to grow individual colonies (a total 151 of 2.3×10 4 ). After rescreening six mutants displayed consistently between 1.2-1.5-fold higher GFP 152 fluorescence upon incubation with 1 mM 13CHD in comparison to media alone, which was a 153 moderate response but statistically significant (p-values < 0.05). These mutants were no longer 154 inducible and even slightly inhibited with 0.1 mM ribose (Table 3 ). In contrast, the same E. coli host 155 expressing wild-type RbsB was not inducible with 13CHD but is 13-fold inducible with 0.1 mM ribose 156 (Table 3 ). Only one of the six mutants (DT016) responded to 1 mM CH with a statistically significant 157 increase in GFP fluorescence (Table 3) . 158 All six recovered mutants contained different amino acid substitutions, with some, but little 159 overlap ( Fig. 2E ). Mutant DT001 displayed five mutations and four wild-type residues at the 9 160 targeted positions, followed by DT011 with 7 mutations, DT015 and DT016 with 8, and clones DT002 161 and DT013 with all 9 targets substituted ( Fig. 2E ). In the majority of the 13CHD-responsive mutants, 162 positions D89, R90 and Q235 were replaced by a polar residue, whereas position T135 was replaced 163 by a non-polar residue. Also, in four of six mutants, N190 was substituted by a histidine ( Fig. 2E ). 164
165
Reduced periplasmic space abundance of RbsB mutants responsive to 13CHD. The relative 166 periplasmic space abundance of four RbsB mutants determined by quantitative mass spectrometry 167 was lower compared to wild-type RbsB ( Table 4 ). The DT002 and DT015 proteins displayed the 168 lowest relative abundance, followed by DT011 and DT001. The periplasmic abundance of mutant 169 DT016 was 2 times higher than RbsB. Interestingly, the relative abundance of MglB (galactose-170 binding protein) was higher in the periplasmic space of E. coli expressing mutants DT011 or DT015, in 171 comparison to those expressing wild-type RbsB or the other mutant proteins (Table 4 ). Also, the 172 summed abundance of all periplasmic binding proteins (excluding RbsB) was higher in all E. coli 173 expressing RbsB mutant proteins than wild-type, with up to between 4.5 and 6 times increase in 174 mutants DT015 and DT011 (Table 4 ). Quantitative mass spectrometry data thus suggest that 175 translocation was affected for most RbsB mutant proteins and that this also influenced the 176 translocation of other periplasmic binding proteins to the periplasm. 177
178
In vitro 13CHD binding by mutant RbsB. Cytoplasmic overexpressed His 6 -tagged RbsB was readily 179 purified and resulted in protein with >97% purity on SDS-PAGE and a molecular mass of around 30 180 kDa as expected ( Fig. 3A , black triangle). Contrary to wild-type RbsB, contaminating proteins were 181 consistently observed in purified His 6 -tagged mutant RbsBs. One or two prominent contaminants 182 with a mass of around 70 kDa were observed after affinity ( Fig. 3B and C, red triangle) and gel-183 filtration columns. These contaminants contributed to an estimated 5-15 % of the total protein 184 quantity. Interestingly, addition of 10 mM ATP to the eluted protein fraction after affinity purification 185 but before gel filtration led to removal of these contaminants ( The RbsB protein fraction after affinity purification and gel filtration was stable and displayed 203 consistent binding to ribose in ITC, even upon -80°C freezing and thawing of aliquoted fractions. In 204 contrast, mutant protein fractions purified in the same manner except for addition of ATP before gel 205 filtration were unstable. Purified DT002-His 6 fractions could be kept on ice for at least 4 h and 206 produced similar heat release in ITC upon addition of 13CHD for three consecutive measurements. In 207 contrast, after freezing at -80°C and thawing, the apparent binding affinity was reduced and 208 sometimes even lost. 13CHD-binding to purified DT016-His 6 disappeared within 2 or 3 h after 209 purification, even while maintaining the protein solution on ice. After -80°C freezing and thawing, 210 the DT016-His 6 protein fraction no longer showed any heat-release from added 13CHD in ITC. These 211 observations and the poor molar ratio of 13CHD binding ( Fig. 4B , C) suggested that the DT002-His 6 212 and DT016-His 6 mutant proteins have strongly reduced stability and spontaneously misfold during 213 purification and ITC. Not unlikely, the other four RbsB mutant proteins already completely misfolded 214 during purification, and no sufficiently stable fractions were obtained to measure productive ligand-215 binding in ITC. 216 217 Secondary structure changes in mutant proteins compared to RbsB. To detect secondary structure 218 differences between wild-type and mutant proteins and observe ligand-induced changes, we 219 analyzed purified protein fractions by circular dichroism spectroscopy in absence and presence of 220 ligand (ribose or 13CHD, Fig. 5 ). All three His-tagged proteins (RbsB, DT002 and DT016) had similar 221 circular dichroism spectra but with different ∆ε intensities, which slightly (RbsB and DT002) or more 222 importantly (DT016) increased upon addition of their ligands ( Fig. 5A ). Secondary structure protein-223 fold predictions from circular dichroism spectra using recently published tools 24 on repeated 224 independently purified protein batches indicated DT002 and DT016 to carry smaller proportions of 225 helices but increased proportions of anti-parallel/parallel and 'turn'-folds compared to RbsB (Fig.  226 5B). This suggests notable distortions in the RbsB-folds as a result of the introduced mutations ( Fig.  227 2). Addition of ribose to RbsB resulted in a notable predicted reduction of the antiparallel-2 relaxed 228 fold (for definition, see Ref 24 ) and an increase of 'other' folds and turns ( Fig. 5B ). This might 229 correspond to the closed configuration of the protein (see, e.g., Fig. 3B in Reimer et al. 13 ). This 230 decrease of the proportion of antiparallel-2 relaxed fold was also observed in one preparation of the 231 purified DT016-protein after addition of 13CHD (see asterisk within Fig. 5B ), but not with addition of 232 ribose or CH. Addition of ligands to DT002 protein preparations did not cause any consistent or 233 pronounced changes in the predicted secondary structure fold composition ( Fig. 5B ). 234
Melting curves of wild-type, DT002 and DT016 purified protein fractions indicated important 235 differences in thermal stability ( Fig. 5C ). Whereas wild-type RbsB showed a melting temperature 236 (Tm) of 58.9±0.1°C (Sigmoidal curve fitting), that of DT016 was only 46.1±0.1°C and that of DT002 not 237 more than 34.7±0.7°C (Fig. 5C ). A robust shift in Tm of ~8°C was observed for RbsB upon addition of 238 0.1 mM ribose ( Fig. 5C ). This result is in accordance with previously reported data 14,25 . In presence of 239 1 mM 13CHD, however, the Tm of RbsB was slightly reduced to 58.5±0.2°C (Fig. 5C ). In contrast, the 240 melting temperatures of mutants DT016 and DT002 were not measurably affected by addition of 241 ribose or 13CHD (Fig. 5C ). This indicated that both DT002 and DT016 mutant proteins were indeed 242 much less stable than wild-type RbsB and that interaction with 13CHD did not further stabilize the 243 proteins. 244 245 Effect of secondary mutations. In order to potentially improve the stability and/or translocation to 246 the periplasm of the two most promising mutants (DT002 and DT016), further targeted mutations 247 were introduced on these proteins. By site-directed mutagenesis H190 was reverted to wild-type 248 N190 in mutant DT002 ( Fig. 2E ). Previous studies indicated the importance of N190 on RbsB stability 249 and/or translocation 13,25 . In the mutant DT016 the residue 235, which had also been suggested to be 250 implicated in RbsB stability 25 , was changed from M235 to V235. Position W164 in the DT016 protein, 251 which is very close to the binding pocket and might block ligand access, was randomized ( Fig. 2D) . 252
Back mutation of H190N in DT002 led to complete loss of inducibility by 13CHD (Table 3) . Also the 253 M235V mutation in mutant DT002 led to complete loss of 13CHD inducibility. Of the randomized 254 positions at W164 in mutant DT016, only a replacement to Gly maintained 13CHD and CH induction 255 (Table 3 ). The periplasmic abundance of DT002 H190N improved compared to DT002, whereas that of 256 DT016 W164G remained the same as that of DT016 (Table 4) model, we showed here that computational predictions of altered amino acid residues in the RbsB 267 binding pocket can indeed lead to a change of functional binding of the cognate substrate (ribose) to 268 foreign but chemically related ligands (13CHD and CH). We acknowledge that although the loss of 269 ribose-binding by the derived mutant RbsB proteins is very clear, the gain of new functionality is 270 detectable but small. The very modest functional gain is not surprising and has been more frequently 271 observed in similar library-screening efforts for altered PBP ligand-binding pocket designs 15 . Our data 272 suggest that the main reason for the limited functional gain is the apparent propensity of RbsB to 273 become misfolded upon mutational redesign of the binding pocket. So far, we have not been able to 274 improve these mutants further by secondary mutations. 275
Several lines of evidence support our conclusion that we obtained a true change of cognate 276 ligand-binding specificity of RbsB to a non-natural ligand, starting from Rosetta simulations and 277 predictions of improved 13CHD-and CH-binding by changes in 9 amino acids. First of all, six different 278 mutant proteins were isolated from the synthesized clone library, with up to 1.5-fold times induction 279 with 13CHD in the E. coli trz1-ompCp-gfpmut2 reporter strain. These mutants had lost completely the 280 capacity to become induced in vivo by ribose, and RbsB as well as the majority of other mutants in 281 the library showed no induction with 13CHD (Table 3) . Further mutation of a number of altered 282 residues in the mutants DT002 and DT016 resulted in loss of 13CHD induction (Table 3) . Secondly, ITC 283 measurements confirmed binding of 13CHD by the mutants DT002 and DT016, with estimated K D of 284 190 µM and 5 µM, respectively ( Fig. 4B, C) . This is indicative for poor binding, but a K D of 5 µM is in 285 the range of measured affinity (1.6 µM) of a grafted L-glutamine-binding domain on the Salmonella 286 typhimurium LAO periplasmic binding protein 15 . Finally, circular dichroism spectroscopy and 287 secondary structure fold-decomposition using a recent new approach 24 indicated structural changes 288 to occur in DT016 upon 13CHD addition (Fig. 5B ), although this was not consistently observed in 289 independent protein preparations. 290
Our results corroborated previous observations that computationally designed PBP variants 291 suffer from misfolding and instability 14, 15 . Despite showing some inducibility in the E. coli signaling 292 reporter chain, four out of six proteins failed to show 13CHD binding in ITC, likely because they 293 unfolded during purification. The two most stable mutant proteins DT002 and DT016, quickly lost 294 functional activity in ITC upon purification and were dramatically less stable than wild-type in 295 thermal denaturation ( Fig. 5C ). All mutant proteins showed evidence for chaperone co-purification 296 after affinity chromatography, indicative for misfolding. This obviously hampers the screening of 297 mutant libraries, given that the procedure relies on functional gain-of-GFP fluorescence (Fig. 1 ). If we 298 assume that the observed induction is a combination of the 'true' affinity of the mutant protein for 299 its new ligand and the ratio of correctly versus misfolded protein, the actual gain of 13CHD-and CH-300 binding may be higher than an induction factor of 1.5 suggests. 301
Detecting and separating mutants from the initial library with such small improvement of 302 inducibility by 13CHD required optimization of the screening method. We initially screened the 303 library for gain-of-fluorescence upon induction on individual cells, but found that single cell variation 304 was too high and resulted in many false-positive signals 30 . Instead, therefore, we switched to growing 305 reporter cells inside alginate beads to microcolonies, which improved the reproducibility and 306 screening efficiency, and reduced the number of false positives. Others have recently compared such 307 procedures and have come to the same conclusion 31 . Surprisingly, around 0.5 % of the clones in our 308 library were constitutively 'ON', showing high GFP fluorescence even in absence of inducer. 309
Constitutives may be the result of combinations of mutations stabilizing the closed configuration 310 without inducer being present. Once in the closed conformation the RbsB 'ON'-mutant may bind to 311 the membrane receptor Trz1 and trigger the bioreporter system. The addition of a step to first sort 312 mutants with lower fluorescence levels in absence of inducer was essential to remove the 313 constitutive 'ON'-mutants and improve the screening efficiency ( Fig. 1A) . 314
What do the recovered mutants tell us about potential ligand-binding in their designed 315 pockets? The ribose-binding pocket of RbsB has been investigated in detail in previous studies. suggested several of those to be limiting 13CHD-or CH-binding by RbsB (Fig. S2 ). In the final 319 computational strategy we stripped the presumed RbsB binding pocket at nine positions (changing 320 virtually to Ala-residues), sampled the positions for 13CHD and CH with the lowest ∆G, and predicted 321 the sets of amino acid residues to contribute with improved 13CHD and CH binding. Although this 322 seemed the best strategy at the time, a more recent and complete Ala-substitution screening of RbsB 323 by our group found four crucial residues for ribose recognition (D89, N190, D215, R141) 13 , two of 324 which (D215, R141) were not included in the library predictions. In contrast, that study found several 325 residues critical for RbsB folding and/or translocation, notably D89 and N190, which were targeted 326 here. Indeed, in four out of the six isolated 13CHD-responsive mutants the D89 residue was 327 substituted by a polar amino acid. The N190 residue was substituted in 5 out of the 6 mutants, of 328 which four times by a histidine, a positively charged amino acid ( Fig. 2E ). This may thus have 329 indirectly contributed to mutant proteins with poorer stability. Perhaps not surprisingly at this stage, 330 several different new binding pocket configurations appeared to confer measurable gain-of-function 331 of 13CHD binding and loss of ribose binding ( Fig. 2E) . These converge to some extent in the character 332 of the newly positioned amino acid residue, but not in their exact type. Given that the modeled 333 mutant protein binding pockets may in reality deviate more than is suggested in Figure 2C and D, it is 334 too speculative to infer how the introduced new amino acid residues might be contributing to the 335 binding of 13CHD. 336
Mass spectra analysis revealed that all 13CHD-responsive mutant proteins, except DT016 and 337 its derivative DT016 W164G , were less abundant in the periplasmic space than wild-type RbsB (Table 4) . 338
This is indirect evidence that the mutant proteins may have additional difficulties in translocation to 339 the periplasm. Cells expressing DT011 and DT015 displayed higher periplasmic levels of MglB and 340 other proteins (Table 4) , which might be due to their increased flux through the Sec-translocation 341 channel in absence of lesser abundant mutant RbsB. In case of cells expressing DT016 or DT016 W164G , 342 periplasmic space abundance of the mutant protein was higher but that of other PBPs was lower, 343 perhaps because of competition with RbsB through the Sec-channel (Table 4 ). In case of DT002, both 344 its own periplasmic space abundance, as well as that of MglB and other PBPs, were lower. This may 345 be the result of a partial blocking of the translocation system by the DT002 protein. Four mutant 346 proteins (DT001, DT002, DT011 and DT015) with lower abundance in the periplasm than wild-type 347
RbsB carried an amino acid substitution at the N190 position. Ala-substitutions at this position 348 resulted in loss of ribose-induction, potential misfolding and/or poor translocation into the 349 periplasm 13,25 . Back mutation of the H190 residue in DT002 to an Asn, indeed increased its 350 periplasmic space abundance (Table 4 ), but also resulted in loss of induction by 13CHD (Table 3) . 351
Mutant DT016, on the other hand, still retained asparagine at position 190 and its periplasmic space 352 abundance was twice as high as wild-type RbsB protein (Table 4 ). Instead, we suspected that the 353 bulky Trp-residue at position 164 in DT016 would limit protein flexibility in the entry and hinge 354 regions (Fig. 2D) , and perhaps be responsible for the high observed fluorescence background in 355 absence of inducer (Table 3) . Indeed, replacing the Trp by a Gly (DT016 W164G ) resulted in a much 356 lower background, similar periplasmic space abundance (Table 4 ) and retainment of 13CHD and CH 357 induction potential (Table 3) 
Materials and Methods
371
Computational design. For in silico design of the mutant library the Rosetta protein design software 372 package was used. In particular, the ligand docking and the enzyme design modules within the 373 Rosetta framework 18 were used to predict amino acid changes in RbsB to potentially allow binding of 374 13CHD and CH. The protein design in Rosetta was carried out as a probabilistic simulated annealing 375 algorithm for exploring the sequence space via rotamer replacement and optimization. The scheme 376 has the following components: I-To parametrize and optimize the interaction via force-field terms; 377 II-To determine the target residue positions to set the design and the one to repack; III-To iterate 378 the cycles of sequence design and minimization; IV-To optimize structures using fixed rotamers 379 without constraints. This defined the key residues in the RbsB binding pocket to be targeted (Table 1, LacI-repressed tac-promoter, and the ompCp-gfpmut2 reporter; strain 4172) 12 (Fig. S2, Table 2 ). 400
Small proportions of these transformed batches were plated to estimate the number of viable clones 401 in the libraries. The remaining pooled library cultures were grown for 16 h in 10 mL of low phosphate 402 minimal medium (MM LP) (Table S1 ) containing 20 mM fumarate as sole carbon and energy source, 403 and supplemented with Ampicillin (Ap) at 100 µg ml -1 and Cm at 30 µg ml -1 to select for both 404 plasmids. Batches of 1.5 mL were aliquoted and stored in 15% (v/v) glycerol at -80°C. 405
Individual mutant clones selected from FABS screening (see below) were grown on LB plus 406 Cm and Ap, and both plasmids (the pSTV28P AA -rbsB-mutant and pSYK1) were purified using 407 NucleoSpin Plasmid columns (Machery-Nagel, Germany). Mutant rbsB genes were recovered on a 408 fragment obtained by digestion with SalI and BstXI or XcmI, which was ligated into vector pET3d cut 409 with the same enzymes 35 (Table S1) (Table S1 ). Recovered beads in the 40-70 µm-diameter range were then incubated for 16 h at 37°C 439 in 5 ml MM LP containing 1 mM fumarate, Ap and Cm, in a rotating wheel (TC-7, New 440 Brunswick/Eppendorf, Belgium). The next day, the cells had grown to microcolonies and individual 441 beads were screened for fluorescence in a FACS Aria flow cytometer particle sorter (BD FACSAria Cell 442
Sorter, Becton Dickinson, USA), equipped with a 100-µm nozzle at a flow rate of 2-5 µl s -1 and a 443 density of between 100-1000 particles µl -1 . Sensitivities for the FSC and FITC channels were set to 444 291 V and 435 V, respectively. 445
Microcolony-in-bead suspensions were screened first without induction and beads with 446 fluorescence less than 1000 units were sorted to deplete the library of constitutive 'ON'-mutants 447 ( Fig. 1A) . Sorted beads were collected in LB medium supplemented with Ap and Cm, and incubated 448 overnight at 37°C and with 180 rpm rotary shaking to dissolve the alginate beads and grow the E. coli 449 cells. Multiple library batches were sorted sequentially to cover the entire mutant library. 450
The library depleted of constitutives was grown in multiple batches on MM with fumarate, 451 cells were encapsulated and grown to microcolonies as described above, followed by 2.5 h induction 452 with 1 mM 13CHD. Microcolony-in-bead fluorescence was again screened by flow cytometry, and 453 beads displaying fluorescence levels higher than 1000 units were sorted in pools by FABS into tubes 454 containing LB plus Ap and Cm medium (Fig. 1B) . The collected beads were dissolved, regrown, and 455 This plate was incubated for another 2 h at 37°C, after which each well was again sampled for cellular 474
fluorescence. As inducers we tested 0.1 mM ribose, 1 mM 13CHD and 1 mM CH (final concentrations 475 in the assay). Cellular fluorescence was measured in 20 µl-aliquots, autosampled from each well by a 476
Novocyte flow cytometer (ACEA Biosciences, USA), at an aspiration rate of 14 µl min -1 and culture 477 density between 1000-5000 cells s -1 . GFP fluorescence was recorded in the FITC-channel, which was 478 set at a sensitivity of 441 V, and is reported as the average of the mean in each of the 8 replicates ± 479 calculated standard deviations. Note that the fluorescence units of the FACS Aria (in Fig. 1) are not 480 the same as the ones from the Novocyte (as in Table 4 ). Statistical significance was tested in pair-481 wise t-tests (one-sided, assuming increased response of the mutant). 482 483 Expression and periplasmic space abundance analysis of RbsB wild-type or mutant proteins. The 484 abundance of RbsB wild-type and mutants in the E. coli periplasmic space was analyzed using direct 485 peptide mass identification, as described previously 12 . Periplasmic fraction was prepared by EDTA-486 ice treatment 12 from E. coli BW25113 ∆rbsB carrying pSYK1 and the pSTVP AA -rbsB derivatives (Table  487 2). Periplasmic protein fractions were separated by SDS-PAGE and proteins in the size range between 488 28 and 36 kDa were excised from the gel. Proteins were analyzed by the UNIL Proteome Facility 489 (https://www.unil.ch/paf/en/home.html). In short: samples were digested with trypsin and peptides 490 were separated on an Ultimate 3000 Nano LC System (Dionex), followed by detection in a Thermo 491 Thawed cell pellets were resuspended in 15 ml of buffer A (500 mM NaCl, 50 mM NaH 2 PO 4 , 502 pH 8.0), containing 20 mM imidazole. The cell suspension was transferred to a metallic chamber 503 containing a single metallic bead (50 ml chamber, Retsch, Germany) and frozen in liquid nitrogen for 504 1 minute. The cold chamber was transferred to a bead-beater machine (Oscillating Mill MM400, 505
Retsch, Germany), and cells were crushed by constant vigorous shaking for 3 min at 30 s -1 . The 506 extract was transferred to a 50 ml centrifuge tube, which was centrifuged at 16,000 × g at 4°C for 30 507 min, after which the lysate supernatant was transferred to a clean tube. 508
The clean lysate was next loaded onto a HisTrap HP column (HisTrap FF crude 1 ml, GE 509 Healthcare) at 4°C and flow rate of 0.5 ml min -1 , followed by washes of, consecutively, 10 column 510 volumes (cv, equal to 1 ml) of buffer A with 20 mM imidazole, 1.5 cv of buffer A with 40 mM 511 imidazole and 1.5 cv of buffer A with 80 mM imidazole. Proteins were eluted with buffer A containing 512 250 mM imidazole in a total volume of 4 ml. The HisTrap eluate was subsequently loaded on a 513 Superdex 200 10/300 GL 24 ml gel filtration column (GE Healthcare), and eluted with buffer A plus 514 250 mM imidazole at a flow rate of 0.75 ml min -1 . Protein eluates were collected in aliquots of 150 515 µl, which were immediately frozen in liquid nitrogen and stored at -80°C, or used immediately for 516 ITC assays. In case of RbsB mutant proteins we tested the effect of adding 10 mM ATP to the eluted 517 protein solution directly after the HisTrap column, in order to disassociate and remove 518 contaminating E. coli chaperones before loading onto the Superdex 200 10/30 GL column. 519 protein extract (mostly the Superdex gel filtration eluate; between 5 and 10 mg protein ml -1 ) was 526 pipetted into the measurement cell of a MicroCal ITC200 isothermal titration calorimetry instrument 527 (GE Healthcare Life Sciences, USA). To avoid potential further unfolding of mutant protein we directly 528 analysed them in imidazole-containing buffer A without previous dialysis, but maintained exactly the 529 same volume of buffer A with 250 mM imidazole in the reference cell. An appropriate concentration 530 of the test ligand (ribose or 13CHD; either at 0.1 or at 1 mM in buffer A with 250 mM imidazole) was 531 filled into the injection syringe. Heat release was measured at 25°C with a reference power of 11 µcal 532 s -1 and a stirring velocity of 1000 rpm. Raw data were recorded as changes in µcal s -1 , and regression 533 curves were fitted based on a one-binding site model using the Microcal Origin software (GE 534 Healthcare). 535
Circular dichroism and variable temperature measurements. Purified wild-type RbsB-His 6 , and 536 DT002-His 6 and DT016-His 6 -mutant proteins were analyzed by circular dichroism spectroscopy and 537 variable temperature measurements using a J810 spectropolarimeter (Jasco, Japan). A volume of 100 538 µl of purified protein immediately after Superdex gel filtration or from thawed protein fraction 539 stored at -80°C, was loaded on a PD minitrap G-25 column (GE Healthcare) and eluted with 500 µl of 540 buffer A to remove the imidazole at 4°C. Protein in buffer A was then kept on ice and analyzed within 541 2 h for its circular dichroism spectrum. 542 Circular dichroism and thermal melting curves were determined in a quartz cuvette with a 543 0.1 cm path length (L). Spectra (θ, mdeg) were measured at room temperature between 200 and 260 544 nm at a scanning speed of 10 nm min -1 and a protein concentration of 0.1 mg ml -1 . Buffer A alone 545 was used as negative control and its circular dichroism spectrum was subtracted from that of the 546 protein fractions. Data were further normalized for Δε (M -1 cm -1 ) using the effective protein 547 concentration (c, mg ml -1 ) and the mean residue weight of RbsB (MRW, 109 Da), as follows: 
